“…Lo et al 7 described 5-year survival rates of 75%, 65.6%, 49%, and 30% for disease stages I, II, III, and IV, respectively. Gonzales-Moles et al 26 showed categorical influence of parameters T, pathologic T, N, and pathologic N on the vital prognosis. Nguyen and Yueh 9 found 1-year survival rates of 60% (stage I) and 32% (stage IV) in patients with recurrence, persistent disease, or second primary cancer.…”